Rhabdoid Tumor - 13 Studies Found
Recruiting |
: Tazemetostat Rollover Study (TRuST): An Open-Label Rollover Study :
|
NOT_YET_RECRUITING |
: Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid Tumors : Rhabdoid Tumor : 2024-09-16 : Patients will receive idasanutlin dosed once daily on Days 1-5 of a 28-day cycle starting with 80% of the RP2D determined in the ongoing pediatric iMA |
RECRUITING |
: Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors : Atypical Teratoid Rhabdoid Tumor : 2024-09-16 : oral, twice daily, dosage per protocol |